Financial Advocates Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$566K Sell
2,193
-379
-15% -$97.8K 0.05% 332
2025
Q1
$576K Buy
2,572
+36
+1% +$8.06K 0.04% 395
2024
Q4
$580K Sell
2,536
-115
-4% -$26.3K 0.03% 412
2024
Q3
$647K Sell
2,651
-157
-6% -$38.3K 0.04% 398
2024
Q2
$537K Buy
2,808
+513
+22% +$98.2K 0.03% 419
2024
Q1
$455K Buy
2,295
+23
+1% +$4.56K 0.03% 473
2023
Q4
$391K Buy
+2,272
New +$391K 0.03% 477
2023
Q3
Sell
-1,255
Closed -$274K 727
2023
Q2
$274K Sell
1,255
-2
-0.2% -$437 0.02% 544
2023
Q1
$275K Sell
1,257
-529
-30% -$116K 0.02% 575
2022
Q4
$372K Buy
+1,786
New +$372K 0.03% 505
2022
Q3
Sell
-5,046
Closed -$1.06M 814
2022
Q2
$1.06M Buy
5,046
+2,033
+67% +$426K 0.09% 257
2022
Q1
$731K Sell
3,013
-145
-5% -$35.2K 0.05% 363
2021
Q4
$823K Sell
3,158
-35
-1% -$9.12K 0.05% 362
2021
Q3
$842K Buy
3,193
+721
+29% +$190K 0.06% 352
2021
Q2
$606K Sell
2,472
-348
-12% -$85.3K 0.04% 429
2021
Q1
$547K Buy
+2,820
New +$547K 0.04% 448